Caxton Associates (New York)’s Encompass Health EHC Stock Holding History

Caxton Associates (New York)’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$480K	Buy	5,203 +336	+7%	+$33K	0.02%	340
2024 Q3	$470K	Buy	+4,867	New	+$437K	0.02%	370
2023 Q3	–	Sell	-8,355	Closed	-$566K	–	463
2023 Q2	$566K	Buy	+8,355	New	+$524K	0.08%	245
2022 Q3	–	Sell	-11,180	Closed	-$499K	–	520
2022 Q2	$499K	Buy	+11,180	New	+$574K	0.05%	276
2019 Q2	–	Sell	-18,335	Closed	-$852K	–	428
2019 Q1	$852K	Buy	18,335 +8,045	+78%	+$408K	0.12%	85
2018 Q4	$505K	Buy	10,290 +6,699	+187%	+$381K	0.08%	120
2018 Q3	$223K	Buy	+3,591	New	+$218K	0.02%	366

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Caxton Associates (New York)'s EHC Position: Q4 2024 in Review

Caxton Associates (New York) increased its Encompass Health (EHC) stake by 6.9% in Q4 2024, buying an estimated $33K and bringing the position to 5,203 shares worth $480K. The position accounts for 0.02% of the portfolio, ranked #340.

Caxton Associates (New York) first reported a position in EHC in Q3 2018 and has held it in 7 quarters since. The position peaked at $852K in Q1 2019. 544 funds tracked by Wall St. Rank hold EHC as of Q4 2024.

Caxton Associates (New York) held 5,203 shares of Encompass Health worth $480K as of Q4 2024.
Caxton Associates (New York) bought 336 Encompass Health shares in Q4 2024, an estimated $33K.
Encompass Health made up 0.02% of Caxton Associates (New York)'s portfolio in Q4 2024, its #340 holding.
Caxton Associates (New York) first reported a position in Encompass Health in Q3 2018 and has held it in 7 quarters since.
Caxton Associates (New York)'s Encompass Health position peaked at $852K in Q1 2019.
544 funds tracked by Wall St. Rank held Encompass Health as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.